Cerba Research
Anaïs Navatel has a diverse work experience in various roles and companies. In 2010, they worked as a Stagiaire at INSERM, where they conducted studies on the virulence genes of E. Coli strains and performed tasks such as bacterial culture, DNA extraction, PCR techniques, and biofilm analysis. In 2011, they were a Stagiaire at Dermadis. Anaïs then joined IDEXX Laboratories in 2012 as a Technicienne de Laboratoire and later worked as a Stagiaire for process validation. At IDEXX from 2013 to 2022, Anaïs held different positions, including Ingenieur Service Technique, Ingenieur Production Matieres Premieres, Support technique Opérations et LEAN, and Assistante Chargé de Projet. Anaïs'sresponsibilities included production and quality control of raw materials, technical support, and project coordination. Currently, Anaïs is working at Cerba Research as the Manager Operations since March 2022.
Anaïs Navatel completed their education in the field of Biotechnology. Anaïs earned a Licentiate degree in Biochemistry and Molecular Biology from Université de Nîmes, which they pursued from 2007 to 2010. Following this, they obtained a Master's degree in Biotechnology from Université de Nîmes, where they studied from 2010 to 2011. Anaïs then continued their studies at Université Joseph Fourier (Grenoble I), where they completed their Master's degree in Biotechnology from 2011 to 2012.
This person is not in any offices
Cerba Research
Cerba Research is the result of the merger of three companies: Barc Lab, Histalim, and Cerba Xpert. Cerba HealthCare owns all three companies and has opted to unite them under one banner. Cerba Research offers quality offers laboratory and diagnostic services, while also harnessing patient data and scientific expertise to help plan and advanceclinical trials. They help global biotech, pharma, and IVD firms to enhance the lives of patients throughout the world by using their worldwide footprint and access to premier regional labs, data, patients, technology, and partnered resources.